Tags |
|
|
Links |
|
|
Main Subject - Organizational Structure, Creativity, Innovation
Organizational structure can inhibit or foster creativity and innovation. The problem with organizational struct
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ure though, is that it is resultant of many factors, including history, organic growth, strategy, operational de
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
sign, product diversity, logistics, marketing, client base, supplier base and so forth. Therefore, what managers
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
need, are not recipes for complete structural change, but insights into the properties of fostering structures t
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
hat can be adapted into the existing structure.
To start, it is useful to analyse the preferred structures agai
To start, it is useful to analyse the preferred structures agai
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
st the not so preferred. There are many definitions of types of organizational structure, but one example is:
a
a
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
) Mechanistic structures (generally not preferred) – includes centralised control and authority, clearly defined
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
tasks, vertical communication links, obedience to supervisors, rigidity and inflexibility.
b) Organic structur
b) Organic structur
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
s (generally preferred) – decentralisation of authority, tasks loosely defined, horizontal communications, great
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
er individual authority, flexible, adaptable.
Experience shows that the above can be misleading. For example, f
Experience shows that the above can be misleading. For example, f
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
at organisations are generally preferred and hierarchical ones not preferred, however, even flat organisations a
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
re in reality hierarchical.
Importantly, if we have a mechanistic structure, what factors allow us to move in t
Importantly, if we have a mechanistic structure, what factors allow us to move in t
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
he right direction without wholesale change?
Some answers include:
a) Direct communication links to decision m
Some answers include:
a) Direct communication links to decision m
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
kers.
b) Communication and information flow between departments.
c) Tangible progression of ideas from problem
b) Communication and information flow between departments.
c) Tangible progression of ideas from problem
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
to solution, product development to commercialisation.
d) Creative teams working outside but linked into the o
d) Creative teams working outside but linked into the o
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ganization, whose culture, processes etc diffuse into the existing structure.
These and other topics are covere
These and other topics are covere
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
d in depth in the MBA dissertation on Managing Creativity & Innovation, which can be purchased (along with a Cre
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ativity and Innovation DIY Audit, Good Idea Generator Software and Power Point Presentation) from http://www.man
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ging-creativity.com
Kal Bishop, MBA
**********************************
You are free to reproduce this article
Kal Bishop, MBA
**********************************
You are free to reproduce this article
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
as long as no changes are made and the author's name and site URL are retained.
Please rate this article below
Please rate this article below
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/24436/mainsubjects-Organizational-Structure-Creativity-Innovation.html">Organizational Structure, Creativity, Innovation</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/24436/mainsubjects-Organizational-Structure-Creativity-Innovation.html]Organizational Structure, Creativity, Innovation[/url]
Related Articles:
Medical Assistant Guide - Essential Duties of Medical Assistants
Secret Revealed In The Business Code
Bookmark it:
|